TH
Trung Huynh RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
57.1%
Neutral
39.3%
Negative
3.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Underperform
Initiated
| $25 |
7%
downside
| 3 | +1.6% |
0
%
| 25 Feb ‘26 13 days ago |
|
|
|
Outperform
Initiated
| $1,250 |
25%
upside
| 4 | +8.6% |
0
%
| 25 Feb ‘26 13 days ago |
|
|
|
Sector Perform
Initiated
| $60 |
1%
downside
| 2 | – |
–
| 25 Feb ‘26 13 days ago |
|
|
|
Outperform
Initiated
| $260 |
14%
upside
| 1 | -0.7% |
0
%
| 25 Feb ‘26 13 days ago |
|
|
|
Outperform
Initiated
| $142 |
20%
upside
| 2 | +4.2% |
0
%
| 25 Feb ‘26 13 days ago |
|
|
|
Neutral
Maintained
| $660 |
15%
downside
| 4 | – |
–
| 7 Nov ‘25 4 months ago |
|
|
|
Buy
Maintained
| $223 |
55%
upside
| 5 | +21% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $25 |
1,699%
upside
| 2 | -46% |
0
%
| 15 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $317 |
16%
downside
| 3 | – |
–
| 6 Aug ‘25 7 months ago |
|
|
|
Buy
Maintained
| $38 |
20%
upside
| 1 | +62% |
0
%
| 9 May ‘25 10 months ago |
|
|
|
Buy
Maintained
| $7 |
105%
upside
| 1 | +143% |
0
%
| 1 Apr ‘25 11 months ago |
|